Diabetes Funding, Quality Initiatives, and U.S. vs. UK Care
This paper examines several dimensions of diabetes management in the United States and, comparatively, the United Kingdom. It begins by outlining public and private funding mechanisms, including the CDC's Division of Diabetes Translation, the Special Diabetes Programs, and the National Diabetes Prevention Program. It then reviews major quality improvement initiatives at both the federal and public-private levels, such as the National Committee for Quality Assurance and the National Diabetes Quality Improvement Alliance. The paper also analyzes the relationship between healthcare coverage and diabetes outcomes, highlighting how uninsured patients face worse health trajectories. Finally, it compares U.S. and UK diabetes care, noting the UK's strengths in care coordination and overall health outcomes despite the U.S. showing some advantages in intermediate patient outcomes.
- Introduction: Diabetes prevalence, burden, and paper scope
- Funding Initiatives: Public and private U.S. diabetes funding programs
- Quality Initiatives: Federal and public-private quality improvement efforts
- Diabetes Care Quality and Healthcare Coverage: Insurance access and its effect on diabetes outcomes
- Diabetes Care in the U.S. and UK: Comparative analysis of U.S. and UK diabetes care
- Conclusion: Summary of findings and persistent challenges
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Integrates multiple authoritative sources — CDC, AHRQ, and peer-reviewed journals — to support each claim, lending credibility to a broad policy overview.
- Follows a clear, logical progression from funding to quality to access to international comparison, allowing each section to build on the last.
- Uses specific statistics (e.g., 9% diagnosed, 23% uninsured) to anchor abstract policy arguments in concrete, verifiable data.
- Frames disparities explicitly, calling attention to disadvantaged populations such as the poor and minorities, which adds social dimension to the health policy discussion.
Key academic technique demonstrated
The paper effectively uses comparative analysis — contrasting the U.S. and UK healthcare systems — to evaluate domestic policy performance. By citing Crosson et al. (2009) and Squires (2011), the author acknowledges complexity: the UK has better care processes and overall outcomes, yet U.S. patients sometimes achieve better intermediate outcomes. This nuanced comparison avoids oversimplification and models how to use international evidence to critique domestic systems.
Structure breakdown
The paper contains six clearly delineated sections: an introduction establishing prevalence and burden; a funding section covering public and public-private mechanisms; a quality initiatives section covering federal and non-profit programs; a section linking insurance coverage to health outcomes; an international comparison of U.S. and UK diabetes care; and a synthesizing conclusion. Each section is compact but substantive, making this a well-organized policy overview suitable as a reference or study guide.
Introduction
Diabetes is one of the major non-communicable diseases today. In the U.S., approximately 9% of the general population have diagnosed or undiagnosed diabetes, with a further 37% estimated to be pre-diabetic (CDC, 2016). The disease increasingly imposes a significant morbidity, economic, mortality, and psychological burden on individuals, families, communities, healthcare organizations, and the government. This paper discusses a number of issues relating to diabetes, including past and present funding initiatives, past and present quality initiatives, the relationship between diabetes care quality and healthcare coverage, and a comparison of diabetes care in the U.S. and UK.
Funding Initiatives
In the U.S., initiatives aimed at preventing diabetes are funded by both the government and private entities. Public funding is executed through the Division of Diabetes Translation (DDT), a unit of the Centers for Disease Control and Prevention (CDC) (CDC, 2016). The DDT funds health departments at the state and local government level in support of programs aimed at preventing or postponing the onset of type 2 diabetes and enhancing health outcomes for diabetic patients.
Other federal initiatives include the Special Diabetes Programs — dedicated mainly to diabetes research — and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a program of the National Institutes of Health. Further funding for diabetes initiatives is provided through the National Diabetes Prevention Program, a public-private partnership that brings together several stakeholders committed to reducing the risk and prevalence of diabetes (CDC, 2016). These stakeholders include government agencies, healthcare organizations, community organizations, employers, and private insurers.
References
Agency for Healthcare Research and Quality (AHRQ). (n.d.). Index of diabetes quality improvement initiatives. Retrieved from https://archive.ahrq.gov/professionals/quality-patient-safety/quality-resources/tools/diabguide/diabqguideapg.html
Casagrande, S., & Cowie, C. (2012). Health insurance coverage among people with and without diabetes in the U.S. adult population. Diabetes Care, 35(11), 2243–2249.
Centers for Disease Control and Prevention (CDC). (2016). Diabetes programs and initiatives. Retrieved from https://www.cdc.gov/diabetes/programs/
Crosson, J., Ohman-Strickland, P., Campbell, S., et al. (2009). A comparison of chronic illness care quality in US and UK family medicine practices prior to pay-for-performance initiatives. Family Practice, 26(6), 510–516.
Jackson, Y., Lozano, J., & Carpentier, M. (2016). Quality of diabetes care and health insurance: a retrospective study in an outpatient academic public hospital in Switzerland. BMC Health Services Research, 16, 540.
Si, D., Bailie, R., Wang, Z., & Weeramanthri, T. (2010). Comparison of diabetes management in five countries for general and indigenous populations: an internet-based review. BMC Health Services Research, 10, 169.
Squires, D. (2011). The U.S. health system in perspective: a comparison of twelve industrialized nations. Issues in International Health Policy, 16, 1–14.
Zhang, J., Huang, E., Drum, M., et al. (2009). Insurance status and quality of diabetes care in community health centers. American Journal of Public Health, 99(4), 742–747.
Create your account
Always verify citation format against your institution’s current style guide requirements.